Morning, Frank. Well, we haven't heard many companies making concrete promises. Most are telling us that they're in talks with the administration and that they don't have anything to share just yet.Now, we have heard a number of CEOs like Lily's CEO Dave Ricks and Merks Rob Davis say that they agree with President Trump that other countries should pay more for drugs, but we haven't seen many actions to actually raise prices elsewhere. Now, Lily and Bristol are making a few tweaks, but nothing groundbreaking ...